Security key
P8696W104
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)
CUSIP: P8696W104
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Shares, par value US$0.001 per share
- Total 13F shares
- 12,345,841
- Total 13F value
- $79,877,748
- Share change
- +12,029,230
- SEC-reported price per share
- $6.47
- Number of holders
- 11
- Value change
- +$74,637,726
- Number of buys
- 9
- Number of sells
- 1
- Shares outstanding
- 71,872,133
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
11
Top holders
10
SVA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
SINOVAC BIOTECH LTD SEC filings
SINOVAC BIOTECH LTD company facts
Broader feeds
Reporting periods
Holder history for CUSIP P8696W104
Recent filing periods:
Ownership snapshot
Top reported holders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
0/5
Latest evidence
31 Dec 2023
13F
Highest disclosed value: $340,000,000
5 rows are not safely comparable across share classes.
Quick read
ORBIMED ADVISORS LLC has the largest disclosed position value at $340M.
0 of 5 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Disclosed position value
Top 5
ORBIMED ADVISORS LLC
$340M
Financial Gravity Asset Managemen...
$3.2M
Neumann Advisory Hong Kong Ltd
$2.04M
Transamerica Financial Advisors, LLC
$1K
Horizon Investments, LLC
$336
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-5 of 5 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$340,000,000
2,718,735 shares
|
— | 31 Dec 2023 |
| Financial Gravity Asset Management, Inc. |
13F
Company
|
—
denominator unverified
|
$3,197,686
973 shares
|
— | 31 Dec 2023 |
| Neumann Advisory Hong Kong Ltd |
13F
Company
|
—
denominator unverified
|
$2,042,000
315,586 shares
|
— | 31 Dec 2023 |
| Transamerica Financial Advisors, LLC |
13F
Company
|
—
denominator unverified
|
$1,000
2 shares
|
— | 31 Dec 2023 |
| Horizon Investments, LLC |
13F
Company
|
—
denominator unverified
|
$336
52 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
12,345,841
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q2 2026 Across Filers
Q2 2026 holders
9
Q1 2024 holders
11
Holder diff
2
| Investor | Q2 2026 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q2 2026 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend